<--- Back to Details
First PageDocument Content
Clinical pharmacology / International Union of Basic and Clinical Pharmacology / Pharmaceuticals policy / Drug discovery / British Pharmacological Society / László Szekeres / Ullrich Georg Trendelenburg / Pharmaceutical sciences / Pharmacology / Medicinal chemistry
Date: 2006-12-28 13:11:19
Clinical pharmacology
International Union of Basic and Clinical Pharmacology
Pharmaceuticals policy
Drug discovery
British Pharmacological Society
László Szekeres
Ullrich Georg Trendelenburg
Pharmaceutical sciences
Pharmacology
Medicinal chemistry

PharmacologyInternational No. 66 Jun 2006 In This Issue Terry P. Kenakin

Add to Reading List

Source URL: www.iuphar.org

Download Document from Source Website

File Size: 192,94 KB

Share Document on Facebook

Similar Documents

SL-35: Oncology Phenotypic Screening. Macrocycles. Phenotypic screening is a firmly established technology that has contributed to the identification of valuable therapeutic agents in oncology drug discovery [1]. For exa

DocID: 1voSH - View Document

Seminars on Drug Discovery & Development Wednesdays 17::00, Lecture Hall 1, Pharmazentrum, Klingelbergstrasse 50, Basel Feb 24, 16 Prof. Dr. G. Klebe, Institute of Pharmaceutical Chemistry, Philipps-University Mar

DocID: 1vnYL - View Document

THE SCIENCE OF BETTER MEDICINES The Harvard Program in Therapeutic Science (HiTS) is building partnerships and developing new ideas and technologies to advance drug discovery and precision medicine.

DocID: 1vnKo - View Document

Scientific Program conferenceseries.com 3rd International Conference and Expo on Drug Discovery & Designing

DocID: 1vngF - View Document

5th CDDD Meeting COMPUTATIONALLY DRIVEN DRUG DISCOVERY November 16-17, 2017 | IFOM, Milan - Italy

DocID: 1vkVj - View Document